Obesity, a complex metabolic disorder influenced by genetic, environmental, and behavioral factors, remains a major risk factor for numerous comorbidities including type 2 diabetes, cardiovascular diseases, and certain cancers. Despite the availability of several pharmacological treatments, the efficacy and safety profiles have often fallen short of expectations. Therefore, the identification of molecular targets that regulate energy homeostasis is critical for developing more effective therapeutics. The melanocortin system, known to play a pivotal role in appetite and body weight regulation, has emerged as a focal point, particularly the MC3R and MC4R subtypes.

The study, led by Seiler, Impastato, Zhang, and colleagues, leverages the intricate biology of the central nervous system circuits that control hunger and satiety by focusing on these two melanocortin receptors. While MC4R has long been recognized for its involvement in appetite suppression and energy expenditure, MC3R has only recently gained attention for its complementary role in energy balance. By simultaneously activating both receptors, the researchers hypothesized a synergistic effect that could enhance anti-obesity outcomes.

Using advanced pharmacological tools, the team designed a dual-action agonist capable of selectively binding and activating MC3R and MC4R in vivo. This compound was administered to male primates with diet-induced obesity, providing a translationally relevant model that closely mimics human physiology and metabolic responses. The experimental design included rigorous monitoring of food intake, body weight, metabolic parameters, and behavioral changes to comprehensively assess efficacy and safety.

Remarkably, the results showed a significant reduction in food consumption following administration of the dual agonist, accompanied by consistent and sustained weight loss over the treatment period. Unlike some previous interventions that triggered compensatory feeding behaviors or adverse effects, this dual activation did not provoke hyperphagia or behavioral stress, suggesting a well-tolerated therapeutic profile. Notably, the weight loss observed was primarily attributed to decreased caloric intake rather than increased physical activity or energy expenditure.

At the molecular level, mechanistic studies demonstrated that MC3R and MC4R engagement modulates neural circuits within the hypothalamus and other brain regions integral to energy homeostasis. Activation of these receptors influenced peptide signaling pathways that regulate hunger hormones, including neuropeptide Y and agouti-related protein, thereby shifting the balance toward satiety. Additionally, downstream effects on peripheral metabolism hinted at favorable impacts on insulin sensitivity and lipid profiles, although further research is required to elucidate these pathways fully.

Importantly, the translational relevance of this approach is underscored by the choice of non-human primates as the experimental model, bridging the gap between rodent studies and human clinical trials. Primates share closer genetic, anatomical, and metabolic characteristics with humans, which enhances the predictive power for therapeutic outcomes. This contrasts with many obesity pharmacotherapy developments that have faltered when moving from rodent models to human subjects due to species-specific differences.

Beyond efficacy, the safety evaluation conducted throughout the study showed no significant adverse events or toxicity. The dual agonist maintained stable cardiovascular parameters, neurobehavioral function, and organ health, addressing longstanding safety concerns associated with melanocortin receptor modulation. These findings indicate that targeted dual activation can achieve a therapeutic window conducive to clinical application.

The implications of this research are vast, as it opens new paths for the treatment of obesity through precise molecular targeting. The dual MC3R/MC4R activation approach could potentially overcome the limitations of existing drugs that target single receptors or pathways, which often result in modest weight loss and undesirable side effects. By fine-tuning the melanocortin system’s regulatory network, more robust and durable weight management may be achievable.

Furthermore, this study invites exploration into combinatorial pharmacotherapies that incorporate receptor duality to modulate complex physiological systems. In the context of obesity, where multifactorial mechanisms underlie dysregulated appetite and metabolism, multifaceted strategies such as dual receptor activation hold considerable promise.

Looking ahead, clinical trials in humans will be crucial to validate these preclinical findings and determine optimal dosing regimens, long-term safety, and efficacy across diverse patient populations. Additionally, investigations into how sex differences, age, and comorbid conditions influence responsiveness to melanocortin receptor-targeted therapies will refine patient stratification and personalized medicine approaches.

This research not only enriches our understanding of hypothalamic control of energy balance but also spotlights the therapeutic potential of simultaneously harnessing multiple receptor pathways. As obesity prevalence continues to escalate globally, innovative interventions like the dual MC3R and MC4R agonist offer hope for more effective, well-tolerated, and sustainable treatments.

The study’s multidisciplinary approach, combining neurobiology, pharmacology, and primate physiology, underscores the importance of integrative research frameworks in addressing complex health issues. By elucidating the nuanced interplay between MC3R and MC4R in weight regulation, the authors have set the stage for transformative advances in obesity therapeutics.

In conclusion, the dual activation of MC3R and MC4R represents a significant leap forward in obesity research, demonstrating potent weight loss effects and appetite suppression in a primate model with compelling translational relevance. These findings herald a new era of receptor-targeted therapies that could revolutionize the management of obesity and related metabolic disorders, promising relief for millions worldwide burdened by the health risks associated with excessive body weight.

Subject of Research: Dual activation of melanocortin receptors MC3R and MC4R for obesity treatment

Article Title: Dual activation of MC3R and MC4R drives weight loss and reduces food intake in male primates with obesity

Article References:
Seiler, J.L., Impastato, A.C., Zhang, E.X. et al. Dual activation of MC3R and MC4R drives weight loss and reduces food intake in male primates with obesity. Nat Commun 17, 4808 (2026). https://doi.org/10.1038/s41467-026-73372-x

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41467-026-73372-x

This groundbreaking study, published in the Journal of Population Economics, leverages a uniquely rich dataset from the National Longitudinal Study of Adolescent to Adult Health (Add Health), which has meticulously tracked over 20,000 Americans from their adolescent years in the mid-1990s into adulthood across six waves of data collection, the latest extending from 2022 to 2025. By integrating not only socioeconomic and health data but also genetic markers related to body weight, the researchers were able to isolate the specific influence of childhood obesity from myriad confounding variables such as family income and neighborhood environments.

The analysis reveals a stark economic penalty associated with childhood obesity, showing that individuals classified as obese during childhood—defined through a Body Mass Index at or above the 95th percentile for their age and sex—occupy adult income percentiles approximately 20 points lower relative to their parents than their normal-weight peers. This decrement in economic status is substantial and persistent, indicating that obesity during formative years casts a long shadow over future earnings potential and social mobility.

Further examining the mechanisms underlying this disparity, the study identifies several contributing factors affecting those who were obese as children. Lower educational attainment emerges as a primary conduit, suggesting that obesity may hinder academic progress or access. Additionally, persistent health complications associated with obesity often reduce workforce participation or limit career advancement. Labor market disadvantages, including reported experiences of job discrimination and occupational segregation into lower-paying jobs, compound the economic setbacks endured by this population.

The geographical and demographic nuances uncovered by the research provide a deeper understanding of the inequality exacerbated by childhood obesity. The economic penalty is especially pronounced for girls, hinting at gender-based differences in social stigma, health outcomes, or labor market treatment related to obesity. Moreover, children from low-income families and those raised in the Southern and Midwestern regions of the country face intensified effects, reflecting broader socioeconomic and regional disparities embedded within the fabric of American society.

This research marks a pivotal departure from prior investigations, which tended to focus heavily on the medical or psychological consequences of childhood obesity, such as social stigma or educational outcomes, without thoroughly analyzing its broader economic repercussions across generations. By establishing a causative link between childhood obesity and diminished intergenerational economic mobility, Jin and her colleagues articulate a compelling argument for reframe public health and social policies.

The implications of these findings extend well beyond individualized health interventions. The entrenched economic disadvantages associated with childhood obesity suggest the need for comprehensive prevention strategies implemented early in life. These preventive measures—ranging from improved nutrition and physical activity programs in schools to community-wide health promotion policies—could yield significant returns, not only by reducing future medical costs but by enhancing educational achievements, increasing labor market success, and bolstering overall economic mobility.

Policy frameworks that address childhood obesity as solely a medical issue may miss critical opportunities to foster more equitable societies. The interconnections between health, education, and economic opportunity highlighted by this study underscore the necessity of integrated approaches that consider the multifaceted nature of social mobility. Addressing childhood obesity proactively can function as a lever to combat persistent income inequality and support the promise of upward mobility that remains central to the American dream.

For Yanhong Jin, a first-generation immigrant, the stakes of this research resonate on a personal level. Long committed to the principle that each generation should surpass the success of the last, Jin’s work underscores an unsettling reality: childhood obesity threatens to undermine this promise, creating a barrier that prevents many young Americans from achieving better economic outcomes than their parents.

Collaborating with economists Maoyong Fan and Man Zhang, Jin’s study employs sophisticated statistical techniques and genetic data analysis to disentangle the complex web of causality, presenting a clear narrative that childhood obesity is more than a health crisis—it is a pivotal economic mobility crisis with profound social implications.

Moreover, the study reveals that individuals who were obese as children tend to reside later in life in neighborhoods characterized by lower economic opportunity, higher poverty rates, and diminished access to resources essential for upward mobility. This spatial dimension of the obesity penalty further entrenches intergenerational disadvantages, revealing a feedback loop that perpetuates both health and economic inequities.

In light of these findings, the imperative for early intervention becomes unmistakable. While treatment and remediation of obesity remain vital, the research compels policymakers, educators, and public health officials to prioritize prevention efforts that begin in childhood or even earlier. By doing so, society can mitigate the long-lasting effects that childhood obesity imposes on economic trajectories and work towards realizing a future where health and economic opportunity are accessible to all children, irrespective of their weight status.

Given the multifactorial nature of obesity and its wide-ranging impacts on individuals and communities, this study not only challenges conventional public health paradigms but also invites new interdisciplinary collaborations. Integrating economic policy with healthcare, education, and social services could unlock innovative solutions that address the root causes of childhood obesity while simultaneously promoting economic equity.

As childhood obesity rates continue to rise globally, the research by Jin and her colleagues serves as a crucial alarm and guide. It demonstrates that the consequences of obesity transcend medical diagnoses and treatment costs, infiltrating societal structures and shaping the life chances of future generations. The path to reversing these trends lies in comprehensive, evidence-based policies that recognize childhood obesity as a critical determinant of long-term economic well-being and social mobility.

Subject of Research: Childhood obesity and its long-term effects on intergenerational economic mobility.

Article Title: Weighing down the future: long‑term effects of childhood obesity on intergenerational mobility

News Publication Date: 17-Feb-2026

Web References: https://doi.org/10.1007/s00148-026-01147-1

Keywords: Childhood obesity, economic mobility, intergenerational mobility, long-term effects, socioeconomic disparities, health economics, genetic markers, labor market discrimination, educational attainment, public health policy, socioeconomic status, prevention strategies

Heat shock proteins are a class of molecular chaperones that play critical roles in cellular stress responses. They assist in the proper folding of proteins, help combat oxidative stress, and maintain cellular homeostasis. HspB1, in particular, has garnered attention for its potential roles in a variety of cellular processes, including apoptosis, inflammation, and metabolic regulation. Given the rising global incidence of obesity and related metabolic disorders such as type 2 diabetes, understanding the role of HspB1 in these conditions is of paramount importance.

The researchers employed a genetically modified mouse model to investigate the effects of HspB1 overexpression on metabolic phenotype. Metabolic syndrome is characterized by a cluster of conditions, including increased blood pressure, high blood sugar levels, excess body fat around the waist, and abnormal cholesterol levels. These factors collectively increase the risk of heart disease, stroke, and diabetes. By modifying the expression levels of HspB1, the study aimed to discern how this protein contributes to or mitigates the effects of metabolic syndrome.

Initial findings indicated that enhanced expression of HspB1 appeared to offer a protective effect against the metabolic disruptions typically observed in obesity. Specifically, the mice that overexpressed HspB1 demonstrated improved insulin sensitivity and better glucose tolerance. This suggests that HspB1 may play a significant role in the regulation of glucose metabolism, potentially making it a key player in the development of obesity-related metabolic conditions.

Intriguingly, the study revealed that the effects of HspB1 were sex-dependent. Male and female mice exhibited differing metabolic responses to the overexpression of this protein. While both sexes showed improvements in specific metabolic parameters, the extent and nature of these changes were markedly different. This finding underscores the importance of considering sex as a biological variable in metabolic research, as male and female bodies respond to metabolic stressors and treatments in distinct ways.

The implications of these findings are profound. As obesity continues to be a pressing public health issue, the development of targeted therapies that take into account sex differences could revolutionize treatment strategies for metabolic disorders. With females and males exhibiting divergent responses to HspB1 overexpression, future therapies could be tailored to address these differences, potentially increasing the efficacy of interventions aimed at mitigating obesity and its metabolic consequences.

Furthermore, the researchers delved into the molecular mechanisms underpinning the observed effects of HspB1. By conducting a series of biochemical assays and gene expression analyses, they were able to elucidate the signaling pathways influenced by HspB1. Notably, the protein’s interaction with key metabolic regulators such as AMP-activated protein kinase (AMPK) and mTOR signaling was highlighted, shedding light on the intricate web of cellular processes that govern metabolic health.

The study also provided insights into the potential for HspB1 to act as a therapeutic target. If future research can confirm these findings in human subjects, HspB1 might emerge as a promising candidate for drug development aimed at obesity and related metabolic disorders. Therapies designed to enhance HspB1 function or mimic its effects could hold great potential for treating conditions such as insulin resistance and type 2 diabetes.

As the research community grapples with the obesity epidemic, studies like this serve as critical stepping stones toward understanding the biological underpinnings of metabolic health. With their focus on the multifaceted role of heat shock proteins, Ruppert and colleagues contribute valuable knowledge to the field, encouraging further investigations into protein functions and their implications for weight management and metabolic regulation.

In conclusion, the study on HspB1 overexpression provides a compelling narrative around the intersection of genetics, sex differences, and metabolic health. As scientists piece together the puzzle of obesity and its related disorders, such insights will be vital for devising innovative approaches to prevention and treatment. Upcoming studies will undoubtedly build on these findings, exploring not just the role of HspB1 but also a plethora of other proteins involved in metabolism, ultimately enhancing our understanding of this complex field. This ongoing research will contribute to initiatives aimed at combating the escalating obesity crisis worldwide, reinforcing the notion that personalized medicine, informed by biological differences, is the future of effective treatment.

Understanding the nuances of metabolic health is not just an academic endeavor; it carries real implications for millions of individuals facing obesity and related conditions. The collaboration between researchers from various fields will be essential as they endeavor to translate laboratory discoveries into viable therapeutic options. Each insight gained, each mechanism elucidated, offers hope for new strategies to combat one of the most significant public health challenges of our time.

Ultimately, the journey of unraveling the complexities of human health and disease is a collective one, reliant on continued research, collaboration, and innovation. The path laid out by the study on HspB1 has opened up new questions and avenues for exploration, ensuring that the dialogue surrounding metabolic health remains dynamic and forward-thinking.

As this area of research progresses, the importance of multidisciplinary approaches must be emphasized. Integrating insights from genetics, biochemistry, and clinical practices will be crucial. By working together, scientists can identify the most promising therapeutic targets and develop interventions that truly address the unique challenges posed by obesity and metabolic disorders.

In summary, this pioneering study sheds light on the significant role of the human heat shock protein B1 in metabolic health, specifically in relation to obesity and its associated conditions. The promise it holds, particularly in a sex-dependent context, has the potential to reshape our understanding and approach to obesity treatment moving forward.

Subject of Research: Human heat shock protein B1 and its impact on obesity-related metabolic changes in a sex-dependent manner.

Article Title: Overexpression of the human heat shock protein B1 alters obesity-related metabolic changes in a sex-dependent manner in a mouse model of metabolic syndrome.

Article References: Ruppert, Z., Sárközy, M., Rákóczi, B. et al. Overexpression of the human heat shock protein B1 alters obesity-related metabolic changes in a sex-dependent manner in a mouse model of metabolic syndrome. Biol Sex Differ 16, 65 (2025). https://doi.org/10.1186/s13293-025-00746-z

Image Credits: AI Generated

DOI: 10.1186/s13293-025-00746-z

Keywords: Heat shock protein B1, metabolic syndrome, obesity, insulin sensitivity, sex differences.

The international team analyzed a massive dataset comprising genetic and health information from over 450,000 participants, primarily of European descent, collected through the UK Biobank. Through a comprehensive genome-wide multi-trait screening approach, they systematically examined genetic loci associated with body fat distribution alongside cardiometabolic traits such as lipid profiles, glucose metabolism, and blood pressure. This integrative method allowed for the identification of 205 specific genetic regions that remarkably link increased body fat with preserved metabolic health.

A particularly novel aspect of the study is the development of a sophisticated genetic risk score that quantifies the cumulative influence of these protective variants. Individuals who scored higher on this scale were genetically predisposed to obesity but paradoxically exhibited fewer metabolic complications commonly associated with excess adiposity. These findings challenge the conventional understanding that obesity uniformly portends elevated risk for diabetes, hypertension, and heart disease, suggesting instead that underlying genetic mechanisms modulate fat cell function to shield certain individuals from such outcomes.

Notably, these protective effects manifested early in life. Children harboring these genetic variants displayed higher body fat percentages, yet did not exhibit the anticipated metabolic disturbances such as insulin resistance or dyslipidemia. This early-life genetic influence hints at an inherent biological divergence in the pathophysiology of obesity itself, which may have profound implications for pediatric health monitoring and intervention strategies.

The study further categorized obesity into eight distinct subtypes, each correlated with a different genetic profile and risk spectrum for metabolic and cardiovascular diseases. These subtypes underscore that obesity is a heterogeneous condition, shaped not only by environmental and lifestyle factors but also by nuanced genetic predispositions that affect fat storage, distribution, and cellular behavior. Such stratification holds potential for transforming clinical practice by allowing physicians to predict which patients are more likely to develop complications and tailor treatment plans accordingly.

From a mechanistic perspective, these genetic findings suggest that alterations in adipocyte biology—how fat cells grow, differentiate, and communicate with other tissues—play a pivotal role in determining metabolic health outcomes in obese individuals. The protective variants appear to promote favorable fat cell functions, such as enhanced lipid storage capacity and reduced inflammation, which mitigate the risk of insulin resistance and cardiovascular disease even in the presence of obesity.

Despite these promising revelations, the researchers emphasize that obesity remains a serious health concern worldwide. They caution that possessing these protective genetic variants does not render obesity harmless; lifestyle factors such as diet quality, physical activity, and psychosocial elements continue to be critical for maintaining overall health and mitigating disease risk.

The scope of this research was primarily limited to individuals of European ancestry, and the team acknowledges the urgent need to expand analyses to more genetically diverse populations. This future work is essential to ensure that genetic insights are broadly applicable and beneficial across different ethnicities and global populations, particularly given the variable prevalence and impact of obesity worldwide.

By disentangling the genetic components that separate metabolically healthy obesity from its harmful forms, this study sets the stage for a more personalized medicine approach to obesity management. Early identification of genetic risk profiles could enable clinicians to implement targeted preventive measures, develop novel therapies that mimic protective genetic pathways, and refine diagnostic tools to better stratify patients based on their true risk.

Moreover, the application of artificial intelligence and advanced computational methods in this study highlights the power of integrating big data and genomics to uncover complex disease mechanisms. It exemplifies how multidisciplinary collaboration can accelerate discovery and translate genetic insights into actionable clinical strategies.

The implications of this research extend far beyond academic curiosity; they pave the way for reshaping public health approaches and medical paradigms regarding obesity. Understanding that obesity is a mosaic of subtypes challenges stigmatization and fosters a more compassionate, scientifically informed dialogue about this global health challenge.

As the field moves forward, the potential to harness these findings into effective interventions is immense. From pharmaceutical innovations that target specific genetic pathways to personalized lifestyle recommendations informed by individual genetics, the future of obesity treatment promises to be more precise, effective, and equitable.

In summary, this landmark study from Mount Sinai and its collaborators represents a profound advance in the genetics of obesity. It reveals the underlying biological diversity of obesity phenotypes and offers hope for mitigating the burden of obesity-related diseases through genetics-guided medical care from childhood onward.

Subject of Research: Genetic determinants of obesity and its metabolic subtypes

Article Title: Mount Sinai Study Reveals Genetic Clues Explaining Why Obesity Affects People Differently

News Publication Date: September 15, 2025

Web References: https://www.nature.com/articles/s41591-025-03931-0

Keywords: Obesity, Genetics, Metabolic Health, Cardiometabolic Traits, Adipocyte Biology, Personalized Medicine, Genetic Risk Score, Genome-wide Association Study

Recent research conducted at the University of Delaware presents promising advancements in understanding obesity at a genetic level. The study, led by Ibra Fancher, an assistant professor of kinesiology and applied physiology, reveals critical insights into how fat tissue—known scientifically as adipose tissue—contributes to obesity and related health issues. Traditionally, adipose tissue has been viewed merely as a storage depot for excess calories; however, emerging science now recognizes this tissue as a complex endocrine organ capable of influencing metabolic health.

In an innovative study published in the journal Physiological Genomics, Fancher and his team explored the effects of diet on gene expression in adipose tissue using an animal model. Two distinct groups were established: one group was subjected to a high-fat, high-caloric diet, reflective of the typical Western dietary pattern, while the other group adhered to a standard chow diet for a period exceeding one year. This controlled environment allowed researchers to closely monitor the impacts of dietary choices on genetic expressions associated with obesity.

The findings were striking. The research uncovered over 300 genes that showed significant differences in expression levels within subcutaneous adipose tissue, which is generally regarded as a less harmful fat type. In contrast, nearly 700 genes exhibited differential expression in visceral adipose tissue. This area of fat, located around vital organs, is known to pose a greater risk for cardiovascular disease and metabolic dysfunction. Fancher elucidates the contrasting roles of these fat tissues, emphasizing that the expansion of visceral fat is both severe and problematic, contributing to the inflammatory processes that underpin many obesity-related conditions.

The core of this groundbreaking research underscores the deleterious effects that poor diet and lack of physical activity can have on specific adipose tissues. By delineating the gene expression profiles in visceral versus subcutaneous fat, Fancher’s team has illuminated viable targets for therapeutic intervention. This work suggests that targeted strategies designed to improve the function of these fat depots could offer significant health benefits and may pave the way for new treatment options for obesity.

Among the many genes analyzed in this study, four stood out as particularly significant, linked to metabolic processes, calcium handling, and inflammation. These candidates present exciting avenues for future research. Fancher posits that further investigation into these specific genes could yield new insights into enhancing adipose tissue function or provide pathways for pharmacological interventions that might mitigate the effects of obesity.

The collaborative effort leveraged the robust capabilities of advanced genomic technologies and bioinformatics available at the University of Delaware. A key player in this endeavor, Bruce Kingham, director of the Sequencing and Genotyping Center, emphasized the importance of these technical resources. Kingham noted that the integration of RNA sequencing and sophisticated data analysis tools allowed researchers to pinpoint obesity-related genetic changes with remarkable clarity. This interdisciplinary approach highlights how collaborative networks can facilitate innovative solutions to complex biomedical problems.

Malak Alradi, a doctoral student specializing in molecular biology and genetics at the University of Delaware, played an essential role in the study by categorizing genes into metabolic pathways. Alradi noted that her initial perceptions of fat as an indistinguishable entity changed significantly through this research. Witnessing the disparities in gene expression between visceral and subcutaneous fat transformed her understanding of how different types of adipose tissue respond to obesity. This insight reinforces the necessity of targeted research approaches that consider the unique biological roles and impacts of various fat types.

Statistical analyses conducted as part of the study confirmed the findings related to adipose depots, revealing important correlations between obesity, metabolism, and inflammation. Fancher expressed a sense of validation regarding the study’s discoveries, emphasizing the novelty and implications of identifying these critical obesity-related genes. This confidence in their results lays the groundwork for further exploration into the mechanisms underlying obesity at the molecular level.

Moving forward, Fancher is poised to extend this research to human adipose tissue samples. In partnership with Dr. Caitlin Halbert, who directs bariatric surgery at ChristianaCare, the team plans to assess whether the differential gene expression patterns observed in animal models translate to human physiology. This step is crucial for verifying the applicability of their findings to clinical settings and may ultimately guide strategies for individualized obesity treatments.

An important aspect of this ongoing research includes investigating potential sex differences in obesity. Fancher notes that biological variability based on sex could prove significant in determining the effective design of targeted interventions. As obesity can influence men and women differently, recognizing these variances could enhance the precision of therapeutic approaches tailored to individual patients.

Ultimately, the University of Delaware’s research contributes profoundly to the understanding of obesity, linking genetic underpinnings to dietary habits and health outcomes. The implications of this work reach far beyond academic circles; they provide a beacon of hope for developing more effective strategies to combat obesity on a public health scale. As researchers continue to unveil the intricacies of adipose tissue function, society stands to benefit from innovative, evidence-based treatments that can effectively address this complex and pervasive health issue.

As this area of inquiry advances, it not only enhances our biological understanding of obesity but also reinforces the critical importance of interdisciplinary collaborations in tackling one of the most significant health challenges of our time.

Subject of Research: Gene expression differences in adipose tissue related to obesity
Article Title: Research at the University of Delaware Uncovers Genetic Insights into Obesity
News Publication Date: 11-Nov-2024
Web References: CDC Obesity Facts
References: Physiological Genomics Article
Image Credits: Ashley Barnas Larrimore/University of Delaware
Keywords: Obesity, Adipose tissue, Gene expression, Metabolic disorders, Health research